The Conference

200+ Speakers. 4 Tracks. One Unmissable Event.

Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, we have content, networking and potential partners for you.

By bringing eight tracks together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine & immunotherapy research, development and manufacture.

Take just three days out of the office to meet over 500+ potential customers who need to find solutions to their challenges. Build three days of totally tailored content and attendees.

PRE-CONFERENCE WORKSHOP

CONFERENCE STREAMS

Immune profiling in infectious disease and cancer

Develop an understanding of the rules of response and protection for vaccines and immunotherapies from novel biomarkers and assays to innovative new technologies disrupting the industry.

In oncology, learn about:

The development of multi-dimensional biomarkers
Next generation single cell sequencing
Characterization of the tumor microenvironment
The use of liquid biopsies as a diagnostic tool

In infectious disease, understand:

How projects like the Immune Epitope Database accelerating the discovery of new targets
The analysis of T-cell responses through TCR repertoire analysis
Protection and waning immunity to current vaccines
How far we’ve come towards an AI model of the human immune system

Cancer Immunotherapy

Stay up-to-date with the fast-moving world of cancer immunotherapy.

Learn more about:

Neoantigen prediction and discovery
Cancer vaccines and oncolytic viruses
Engineered cell therapies and antibody-based therapies
Checkpoint inhibitors and other immunomodulatory targets as monotherapies and in combination

Delve deeper into what the development of these therapies teaching us about understanding mechanisms of immune suppression and resistance, and how this informs new therapies that will overcome them.

Moving forward, what will be the impact of moving to earlier lines of therapy in cancer? Hear from key opinion leaders in oncology about how this affects the way with think about cancer immunotherapy strategies.

Vaccine Development

Discover the most recent advances in bacterial vaccine development; from TB and E. coli to Lyme and Shigella, as well as healthcare associated infections like C. diff.

Agenda topics include:
National strategies to combat ant-microbial resistance
Efforts to develop novel influenza vaccines from seasonal and pandemic
Progress in the development of a universal flu vaccine
Respiratory vaccines such as RSV and MERS
Biotechs platforms to counter emerging threats such as Dengue, Malaria, Zika and Ebola
Passive immunity strategies
Development of antibody-based therapies against infectious diseases

Delivery Bioprocessing and Manufacture

Discover the latest technologies improving vaccine and and immunotherapy delivery including:

Needle-free delivery systems
Nano-patches
Vector mediated antigen delivery
The latest advances in the engineering of antibody therapies for selective binding, more stable linker technology
Plant-based production platforms
Scaling up of t-cell therapies
Production platforms to respond to emerging threats

New Technology

New technologies are transforming both the vaccines and immunotherapy space.

Join us to learn about:

The latest advances in bioinformatic tools
Applications of machine learning and AI
New platform technologies that are helping to accelerate therapies from bench to bedside

Pre-Clinical and Clinical Development

All your clinical development questions will be covered, including:

The use of animal models to inform pre-clinical development
Patient selection strategies
Running clinical trials in an international setting
Clinical efficacy, human challenge studies, real word evidence
Phase 4 / 5 trials to support post-licensure safety studies